Detalhe da pesquisa
1.
Association between Subjective Cognitive Complaints and Incident Functional Impairment in Parkinson's Disease.
Mov Disord
; 39(4): 706-714, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38318953
2.
Selected autonomic signs and symptoms as risk markers for phenoconversion and functional dependence in prodromal Parkinson's disease.
Clin Auton Res
; 32(6): 463-476, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36057046
3.
Early Autonomic Symptoms Predict Functional Decline in Parkinson's Disease Independent of Dopaminergic Therapy.
Neurodegener Dis
; 22(1): 15-23, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35785765
4.
Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease.
Ann Neurol
; 88(3): 574-587, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32542885
5.
Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease.
Mov Disord
; 36(8): 1972-1978, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33942926
6.
Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?
Mov Disord
; 35(9): 1618-1625, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32520435
7.
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression.
Mov Disord
; 35(11): 1999-2008, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32798333
8.
Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.
Mov Disord
; 35(5): 833-844, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32073681
9.
Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease.
Mov Disord
; 34(9): 1354-1364, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31361367
10.
Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort.
J Neurol Neurosurg Psychiatry
; 89(1): 78-88, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28986467
11.
APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.
Mov Disord
; 33(2): 289-297, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29168904
12.
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort.
Mov Disord
; 33(5): 771-782, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29572948
13.
Cognition and the course of prodromal Parkinson's disease.
Mov Disord
; 32(11): 1640-1645, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29063713
14.
Changes in Self-Reported Energy Levels in Prodromal Parkinson's Disease.
Mov Disord
; 36(5): 1276-1277, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33634907
15.
Sleep and circadian rhythms in the treatment, trajectory, and prevention of neurodegenerative disease.
Neurobiol Dis
; 145: 105075, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32890772
16.
In Their Own Words: Fears Expressed by People with Parkinson's Disease in an Online Symptom Database.
J Parkinsons Dis
; 14(4): 865-872, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38669556
17.
Chronotropic Incompetence During Exercise Testing as a Marker of Autonomic Dysfunction in Individuals with Early Parkinson's Disease.
J Parkinsons Dis
; 14(1): 121-133, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38189712
18.
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research.
Lancet Neurol
; 23(2): 178-190, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38267190
19.
Role of novel endpoints and evaluations of response in Parkinson disease.
Handb Clin Neurol
; 193: 325-345, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36803820
20.
Proposal for a Biologic Staging System of Parkinson's Disease.
J Parkinsons Dis
; 13(3): 297-309, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37066922